Publications by authors named "Joseph Espat"

Claim this Profile
W
Well-differentiated grade 1 and 2 nonfunctioning pancreatic neuroendocrine tumor: Consideration of additional factors to aid treatment decision-making.
Omid Salehi, Ponnandai Somasundar, N Joseph Espat, Abdul Saied Calvino, Mohammad Ali

Am J Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the role of thyroidectomy in patients with metastatic differentiated thyroid carcinoma by age groups.
Heenaben Patel, Ponnandai Somasundar, N Joseph Espat, Abdul S Calvino, Steve Kwon

Am J Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Updated Sarculator Nomogram for Primary Retroperitoneal Sarcoma in the United States.
Mason Stillman, N Joseph Espat, Steve Kwon

Ann Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in use and outcomes of robotic surgery for gastric cancer: An evaluation of a large national cohort.
Hanna Wang, N Joseph Espat, Abdul S Calvino, Ponnandai Somasundar, Steve Kwon

Surgery· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic resection versus gastrectomy for clinical T1a gastric adenocarcinoma: Predictors of nodal upstaging.
Omid Salehi, Ponnandai Somasundar, N Joseph Espat, Abdul Saied Calvino, Mohammad Ali

Surgery· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of cancer-directed surgical therapy in Medicaid patients with cancer: comparison between low/intermediate/high-risk surgeries.
Heenaben Patel, Mohammad S Ali, Jae-Yong Ahn, N Joseph Espat, Abdul S Calvino

Cancer Causes Control· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hispanic Patients Reported Factors for Colonoscopy "No-Shows" Despite a Culturally Tailored Patient Navigation Program.
Kirby Walker, Carl Winkler, Victoria Baggio, N Joseph Espat, Abdul Saied Calvino

J Immigr Minor Health· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional Hepatic Therapies for Colorectal Hepatic Metastases.
Andrew B Crocker, Munya H Talukder, Mohammad S Ali, Abdul Saied Calvino, Ponnandai Somasundar, N Joseph Espat

R I Med J (2013)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of American College of Surgeons Geriatric Surgery Verification Program in Patients Undergoing Major Abdominal Oncologic Operation at a Cancer Center.
Mercy Jimenez, Omid Salehi, Ponnandai Somasundar, Jayme Dandeneau, Joanna Chebl, N Joseph Espat

J Am Coll Surg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of medicaid expansion on screenable versus non-screenable gastrointestinal cancers.
Omid Salehi, Kanishka Uttam Chandani, Cara J Sammartino, Ponnandai Somasundar, N Joseph Espat

J Cancer Policy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of older patients undergoing major oncological surgery: Insights from the Geriatric Surgery Verification Program.
Omid Salehi, Irving Zhao, Joanna Abi Chebl, Ponnandai Somasundar, Lidia Vognar, N Joseph Espat

J Geriatr Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of immunotherapy on the care patterns and outcomes of patients with advanced hepatocellular carcinoma.
Aryanna Sousa, Qusai Al Masad, Paola Pena, N Joseph Espat, Abdul S Calvino

Clin Res Hepatol Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of Time to First Therapy and Survival Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery Approach in Resectable Pancreatic Ductal Adenocarcinoma.
Qusai Al Masad, Aryanna Sousa, Paola Pena, Cara J Sammartino, Ponnandai Somasundar, N Joseph Espat

J Surg Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative Impact of Systemic Therapy on Survival in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Low-Grade Metastatic Appendiceal Adenocarcinoma.
Mason Stillman, Ponnandai Somasundar, N Joseph Espat, Abdul S Calvino, Steve Kwon

Ann Surg Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in utilization of novel cancer therapies in advanced stage III and IV melanoma and variance in outcomes.
Mohammad S Ali, Jae Ahn, N Joseph Espat, Abdul S Calvino, James Koness

Immunotherapy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreasing colorectal cancer screening disparities: A culturally tailored patient navigation program for Hispanic patients.
Carl S Winkler, John C Hardaway, M Erkan Ceyhan, N Joseph Espat, Abdul Saied Calvino

Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrolamellar Carcinoma: Novel Insights into a Rare Subtype.
Asish Patel, N Joseph Espat, Ponnandai Somasundar

Ann Surg Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA liver metastases.
Steven C Katz, John Hardaway, Ethan Prince, Prajna Guha, Marissa Cunetta, N Joseph Espat

Cancer Gene Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm.
D Rohan Jeyarajah, Maria B Majella Doyle, N Joseph Espat, Paul D Hansen, David A Iannitti

J Gastrointest Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.
Prajna Guha, Jillian Gardell, Josephine Darpolor, Marissa Cunetta, Matthew Lima, N Joseph Espat

Oncogene· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
Chandrajit P Raut, N Joseph Espat, Robert G Maki, Dejka M Araujo, Jonathan Trent

JAMA Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline Science: Functionally impaired geriatric CAR-T cells rescued by increased α5β1 integrin expression.
Prajna Guha, Marissa Cunetta, Ponnandai Somasundar, N Joseph Espat, Richard P Junghans

J Leukoc Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer.
Ali Ahmad, Jeffrey Reha, Abdul Saied, N Joseph Espat, Ponnandai Somasundar

Hepatobiliary Surg Nutr· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of surgical non-referral for colorectal liver metastases.
Ali Ahmad, Jeffrey Reha, Ponnandai Somasundar, N Joseph Espat, Steven C Katz

J Surg Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.
Steven C Katz, Rachel A Burga, Elise McCormack, Li Juan Wang, Wesley Mooring, N Joseph Espat

Clin Cancer Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis